Neisseria gonorrhoeae , responsible for the sexually transmitted infection gonorrhea, is becoming increasingly difficult to ...

Omadacycline tosylate is under clinical development by Paratek Pharmaceuticals and currently in Phase I for Osteomyelitis.

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

The emergence of Neisseria gonorrhoeae strains resistant to ceftriaxone, the last reliable treatment, poses significant ...